RETRACTED: CCDC88A Post-Transcriptionally Regulates VEGF via miR-101 and Subsequently Regulates Hepatocellular Carcinoma

Qiongying Hu, Yuchen Li, Hongqing Chen, Hongyan Liao, Yong He, Qin Zheng

Open source

DOI
10.3389/fimmu.2022.859331
Published
2022-04-13
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2022.859331,
  title = {RETRACTED: CCDC88A Post-Transcriptionally Regulates VEGF via miR-101 and Subsequently Regulates Hepatocellular Carcinoma},
  author = {Qiongying Hu and Yuchen Li and Hongqing Chen and Hongyan Liao and Yong He and Qin Zheng},
  year = {2022},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2022.859331},
  url = {https://doi.org/10.3389/fimmu.2022.859331}
}

RIS

TY  - JOUR
TI  - RETRACTED: CCDC88A Post-Transcriptionally Regulates VEGF via miR-101 and Subsequently Regulates Hepatocellular Carcinoma
AU  - Qiongying Hu
AU  - Yuchen Li
AU  - Hongqing Chen
AU  - Hongyan Liao
AU  - Yong He
AU  - Qin Zheng
PY  - 2022
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2022.859331
UR  - https://doi.org/10.3389/fimmu.2022.859331
ER  - 

APA

Hu, Q., Li, Y., Chen, H., Liao, H., He, Y., & Zheng, Q. (2022). RETRACTED: CCDC88A Post-Transcriptionally Regulates VEGF via miR-101 and Subsequently Regulates Hepatocellular Carcinoma. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2022.859331

Source records